Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
49,594,356
-
Total 13F shares
-
1,626,748
-
Share change
-
+1,104,505
-
Total reported value
-
$1,183,000
-
Price per share
-
$0.73
-
Number of holders
-
18
-
Value change
-
+$802,390
-
Number of buys
-
10
-
Number of sells
-
5
Institutional Holders of PDS Biotechnology Corp - Common (PDSB) as of Q1 2020
As of 31 Mar 2020,
PDS Biotechnology Corp - Common (PDSB) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,626,748 shares.
The largest 10 holders included
FEDERATED HERMES, INC., RENAISSANCE TECHNOLOGIES LLC, Worth Venture Partners, LLC, FIRST MANHATTAN CO, Sofinnova Investments, Inc., New Leaf Venture Partners, L.L.C., Hudson Bay Capital Management LP, MILLENNIUM MANAGEMENT LLC, UBS Group AG, and Bank of New York Mellon Corp.
This page lists
18
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.